Reaction for the synthesis of benzimidazol-2-ones, imidazo[5,4-b]-, and imidazo[4,5-c]pyridin-2-ones via the rearrangement of quinoxalin-2-ones and their aza analogues when exposed to enamines.
暂无分享,去创建一个
N. Zhukova | V. Mamedov | S. Latypov | I. Rizvanov | V. Syakaev | T. N. Beschastnova | A. I. Zamaletdinova | Milyausha S. Kadyrova
[1] N. Zhukova,et al. An efficient metal-free synthesis of 2-(pyrazin-2-yl)benzimidazoles from quinoxalinones and diaminomaleonitrile via a novel rearrangement , 2012 .
[2] V. Mamedov,et al. Recyclization reactions leading to benzimidazoles , 2011 .
[3] S. Boncel,et al. Michael versus retro-Michael reaction in the regioselective synthesis of N-1 and N-3 uracil adducts , 2010 .
[4] E. De Clercq,et al. Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. , 2010, Bioorganic & medicinal chemistry.
[5] V. Singh,et al. Asymmetric organocatalytic Michael-type reaction of phosphorus ylides to nitroolefins: synthesis of γ-nitro-β-aryl-α-methylene carboxylic esters , 2010 .
[6] Yongwen Jiang,et al. Assembly of substituted 1H-benzimidazoles and 1,3-dihydrobenzimidazol-2-ones via CuI/L-proline catalyzed coupling of aqueous ammonia with 2-iodoacetanilides and 2-iodophenylcarbamates. , 2009, The Journal of organic chemistry.
[7] A. Gubaidullin,et al. Efficient synthesis of 2-(pyrazol-3-yl)benzimidazoles from 3-arylacylidene-3,4-dihydroquinoxalin-2(1H)-ones and hydrazine hydrate via a novel rearrangement , 2009 .
[8] C. Pannecouque,et al. Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents. , 2009, Bioorganic & medicinal chemistry.
[9] A. Gubaidullin,et al. An efficient one-step method for the synthesis of 2-(indolizin-2-yl)benzimidazoles from quinoxalinones and α-picoline via a novel rearrangement , 2008 .
[10] R. SanMartin,et al. Copper-catalyzed intramolecular N-arylation of ureas in water: a novel entry to benzoimidazolones , 2008 .
[11] Hualiang Jiang,et al. Copper-catalyzed intramolecular cyclization to N-substituted 1,3-dihydrobenzimidazol-2-ones. , 2008, Organic letters.
[12] V. Mamedov,et al. Quinoxaline-benzimidazole rearrangements in the reactions of 3-alkanoylquinoxalin-2-ones with 1,2-phenylenediamines , 2007 .
[13] D. Ma,et al. Cascade coupling/cyclization process to N-substituted 1,3-dihydrobenzimidazol-2-ones. , 2007, Organic letters.
[14] A. Marino,et al. Respiratory syncytial virus fusion inhibitors. Part 4: optimization for oral bioavailability. , 2007, Bioorganic & medicinal chemistry letters.
[15] Y. Zong,et al. Microwave-assisted traceless synthesis of benzimidazolones , 2007 .
[16] M. Hao,et al. Discovery and design of benzimidazolone based inhibitors of p38 MAP kinase. , 2006, Bioorganic & medicinal chemistry letters.
[17] Cory R. Theberge,et al. Identification of novel, orally bioavailable spirohydantoin CGRP receptor antagonists. , 2006, Bioorganic & medicinal chemistry letters.
[18] M. Guillaume. Expeditious process improvement for the synthesis of RWJ-333966 , 2006 .
[19] I. Davies,et al. Efficient access to cyclic ureas via Pd-catalyzed cyclization. , 2006, Organic letters.
[20] R. Winneker,et al. SAR studies of 6-aryl-1,3-dihydrobenzimidazol-2-ones as progesterone receptor antagonists. , 2005, Bioorganic & medicinal chemistry letters.
[21] Jan Balzarini,et al. Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT. , 2005, Journal of medicinal chemistry.
[22] Jianmei Wei,et al. Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitors. , 2005, Bioorganic & medicinal chemistry letters.
[23] M. Kassiou,et al. Synthesis, radiosynthesis and in vivo evaluation of 5-[3-(4-benzylpiperidin-1-yl)prop-1-ynyl]-1,3-dihydrobenzoimidazol-2-[(11)C]one, as a potent NR(1A)/2B subtype selective NMDA PET radiotracer. , 2003, Bioorganic & medicinal chemistry.
[24] C. Claver,et al. Synthesis of 2-substituted-benzothiazoles by palladium-catalyzed intramolecular cyclization of o-bromophenylthioureas and o-bromophenylthioamides , 2003 .
[25] A. Alexakis,et al. Asymmetric Michael Addition of α-Hydroxyketones to Nitroolefins Catalyzed by Chiral Diamine , 2003 .
[26] S. Matsunaga,et al. Direct catalytic asymmetric Michael reaction of hydroxyketones: asymmetric Zn catalysis with a Et2Zn/linked-BINOL complex. , 2003, Journal of the American Chemical Society.
[27] D Horvath,et al. From hit to lead. Combining two complementary methods for focused library design. Application to mu opiate ligands. , 2001, Journal of medicinal chemistry.
[28] Y. Iwasawa,et al. Synthesis of J-113397, the first potent and selective ORL1 antagonist , 2001 .
[29] A. Orjales,et al. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives. , 1999, Journal of medicinal chemistry.
[30] W. Vaalburg,et al. Synthesis and evaluation of (S)-4-(3-(2'-[C-11]isopropylamino)-2-hydroxy-propoxy)-2H-benzimidazol-2-one ((S)-[C-11]CGP 12388) and (S)-4-(3-((1'-[F-18]-fluoroisopropyl)amino)-2-hydroxypropoxy)-2H-benzimidazol-2-one ((S)-[F-18]Fluoro-CGP 12388) for visualization of beta-adrenoceptors with positron emi , 1997 .
[31] A. J. Shaka,et al. One-Dimensional NOE Experiments Using Pulsed Field Gradients , 1997 .
[32] A. J. Shaka,et al. Excitation Sculpting in High-Resolution Nuclear Magnetic Resonance Spectroscopy: Application to Selective NOE Experiments , 1995 .
[33] Z. Rappoport. The chemistry of enamines , 1994 .
[34] R. Henning,et al. Synthesis and neuroleptic activity of a series of 1-[1-(benzo-1,4-dioxan-2-ylmethyl)-4-piperidinyl]benzim idazolone derivatives. , 1987, Journal of medicinal chemistry.